Who makes [18F]F-RESCA-R8B4?

[18F]F-RESCA-R8B4 is developed by RenJi Hospital.

What development phase is [18F]F-RESCA-R8B4 in?

[18F]F-RESCA-R8B4 is in Phase 1.

Last reviewed 2026-04-20 · How we verify

[18F]F-RESCA-R8B4

RenJi Hospital · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	[18F]F-RESCA-R8B4
Also known as	[18F]R8B4
Sponsor	RenJi Hospital
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]F-RESCA-R8B4 CI brief — competitive landscape report
[18F]F-RESCA-R8B4 updates RSS · CI watch RSS
RenJi Hospital portfolio CI